In an administrative complaint filed Dec. 18, the FTC said the proposed merger would likely do harm to consumers by causing healthcare costs to rise and diminishing incentives for the combined entity to upgrade services and improve quality. If the two organizations combined, they would operate a majority of the hospitals in the Chicagoland area and control more than 50 percent of the area’s general acute care inpatient hospital services, according to the FTC.
On Dec. 21, the FTC and the Illinois attorney general filed a complaint seeking a preliminary injunction to prevent the health systems from moving forward with their merger while the FTC conducts its antitrust review.
Although the two hospital chains have agreed to put the merger on hold, they intend to oppose the FTC’s request for an injunction. U.S. District Court Judge Jorge Alonso is slated to hear the FTC’s arguments for an injunction starting April 6, 2016, according to the report.
More articles on antitrust issues:
FTC official: ‘The goals of the ACA and antitrust are in harmony’
Researchers use hospital prices to show need to ‘combat market power’
How ACOs can avoid antitrust scrutiny
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
